Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Florentin

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|July 7, 1992
Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the ratY L Chen, I Florentin, A M Batt, et al.
Progress in Experimental Tumor Research|January 1, 1980
Active immunotherapy of cancer for minimal residual disease: new trends and new materialsG Mathé, I Florentin, L Olsson, et al.
European Journal of Cancer|November 1, 1975
The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extractG Mathe, O Halle-Pannenko, I Florentin, et al.
Transplantation Proceedings|March 1, 1973
Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigensG Mathé, N Kiger, I Florentin, et al.
Inflammation|December 1, 1991
Modification of inflammatory processes by phenobarbital in ratsF E Levy, L Chauvelot-Moachon, I Florentin, et al.
Canadian Journal of Physiology and Pharmacology|March 10, 2001
[Induction of apoptosis of splenic lymphocytes in mice by accelerated carbon ions]V Holl, D Coelho, D Weltin, et al.
Life Sciences|January 1, 1993
Inhibition of human monocyte TNF production by adenosine receptor agonistsV Le Vraux, Y L Chen, I Masson, et al.
Journal of Leukocyte Biology|January 1, 1994
Restoration of postburn impaired lymphocyte responsiveness by nonsteroidal anti-inflammatory drugs is independent of prostaglandin E2 inhibitionJ Mathieu, I Masson, Y Chancerelle, et al.
Annals of the New York Academy of Sciences|January 1, 1983
Immunopharmacological properties of tuftsin and of some analoguesI Florentin, J Martinez, J Maral, et al.
Cancer Treatment Reports|November 1, 1978
Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapyG Mathé, I Florentin, L Olsson, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|July 7, 1992
Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the ratY L Chen, I Florentin, A M Batt, et al.
Progress in Experimental Tumor Research|January 1, 1980
Active immunotherapy of cancer for minimal residual disease: new trends and new materialsG Mathé, I Florentin, L Olsson, et al.
European Journal of Cancer|November 1, 1975
The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extractG Mathe, O Halle-Pannenko, I Florentin, et al.
Transplantation Proceedings|March 1, 1973
Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigensG Mathé, N Kiger, I Florentin, et al.
Inflammation|December 1, 1991
Modification of inflammatory processes by phenobarbital in ratsF E Levy, L Chauvelot-Moachon, I Florentin, et al.
Canadian Journal of Physiology and Pharmacology|March 10, 2001
[Induction of apoptosis of splenic lymphocytes in mice by accelerated carbon ions]V Holl, D Coelho, D Weltin, et al.
Life Sciences|January 1, 1993
Inhibition of human monocyte TNF production by adenosine receptor agonistsV Le Vraux, Y L Chen, I Masson, et al.
Journal of Leukocyte Biology|January 1, 1994
Restoration of postburn impaired lymphocyte responsiveness by nonsteroidal anti-inflammatory drugs is independent of prostaglandin E2 inhibitionJ Mathieu, I Masson, Y Chancerelle, et al.
Annals of the New York Academy of Sciences|January 1, 1983
Immunopharmacological properties of tuftsin and of some analoguesI Florentin, J Martinez, J Maral, et al.
Cancer Treatment Reports|November 1, 1978
Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapyG Mathé, I Florentin, L Olsson, et al.
Pageof 9